FDA approves new treatment for Alzheimers disease | WNT
BioGens Aduhelm is a monthly injection intended to slow cognitive decline in patients with early stages of the disease. The…
Controversy over newly approved Alzheimer’s drug
The FDA approved Biogens Aducanumab after its own independent recommended that it be rejected. source